JAKARTA, Indonesia, Jan. 12, 2021 /PRNewswire/ -- Indonesian paint manufacturer PT Mowilex is safeguarding workers' health by purchasing COVID-19 diagnostic tests from U.S. health care company Abbott. PT Mowilex will roll out an aggressive testing program to enhance distancing and hygiene protocols it adopted in early March 2020. Niko Safavi. COVID-19 has profoundly impacted manufacturing companies, as many functions cannot be performed remotely. Furthermore, guidelines for the Jakarta region require that companies in breach of distancing and hygiene protocols may face mandatory closures of up to two weeks. "We know that the health and safety of our employees are directly linked to our company's health. And while efficiencies and productivity have suffered over the last year, we know acting early and aggressively reduces our risks considerably," said Safavi. In addition to implementing a companywide pandemic mitigation plan in March, PT Mowilex has responded to COVID-19 by donating personal protective equipment (PPE) to area hospitals. The company also made hand sanitizer to donate throughout local communities, following a widespread sanitizer shortage in March. About PT Mowilex Indonesia PT Mowilex Indonesia (PT Mowilex), a subsidiary of Asia Coatings Enterprises, Pte. Ltd., is a leading producer of premium paints and coatings. Since launching the first Indonesian-made, water-based paints in 1970, the community-minded company has expanded its commitment to environmental ethics, equality and innovation. PT Mowilex is Indonesia's only certified carbon-neutral manufacturer, producing zero- and low-VOC paints in modern colours, and the company regularly earns awards for its corporate social responsibility and sustainability efforts.
By PR Newswire